184 related articles for article (PubMed ID: 8115426)
21. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.
Thomas BF; Wei X; Martin BR
J Pharmacol Exp Ther; 1992 Dec; 263(3):1383-90. PubMed ID: 1335065
[TBL] [Abstract][Full Text] [Related]
22. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.
Breivogel CS; Scates SM; Beletskaya IO; Lowery OB; Aceto MD; Martin BR
Eur J Pharmacol; 2003 Jan; 459(2-3):139-50. PubMed ID: 12524139
[TBL] [Abstract][Full Text] [Related]
23. Competitive inhibition of delta8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding.
Yamamoto I; Kimura T; Kamei A; Yoshida H; Watanabe K; Ho IK; Yoshimura H
Biol Pharm Bull; 1998 Apr; 21(4):408-10. PubMed ID: 9586583
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
[TBL] [Abstract][Full Text] [Related]
25. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice.
Breivogel CS; Vaghela MS
J Recept Signal Transduct Res; 2015 Feb; 35(1):98-106. PubMed ID: 25779032
[TBL] [Abstract][Full Text] [Related]
26. Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas.
Rodríguez De Fonseca F; Fernández-Ruiz JJ; Murphy LL; Cebeira M; Steger RW; Bartke A; Ramos JA
Pharmacol Biochem Behav; 1992 Jun; 42(2):269-75. PubMed ID: 1321451
[TBL] [Abstract][Full Text] [Related]
27. Determination and characterization of a cannabinoid receptor in rat brain.
Devane WA; Dysarz FA; Johnson MR; Melvin LS; Howlett AC
Mol Pharmacol; 1988 Nov; 34(5):605-13. PubMed ID: 2848184
[TBL] [Abstract][Full Text] [Related]
28. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
Petitet F; Jeantaud B; Reibaud M; Imperato A; Dubroeucq MC
Life Sci; 1998; 63(1):PL1-6. PubMed ID: 9667767
[TBL] [Abstract][Full Text] [Related]
29. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
Rubino T; Viganò D; Costa B; Colleoni M; Parolaro D
J Neurochem; 2000 Dec; 75(6):2478-84. PubMed ID: 11080200
[TBL] [Abstract][Full Text] [Related]
30. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study.
Rubino T; Massi P; Patrini G; Venier I; Giagnoni G; Parolaro D
Neuroreport; 1994 Dec; 5(18):2493-6. PubMed ID: 7696588
[TBL] [Abstract][Full Text] [Related]
31. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol.
García-Gil L; Romero J; Ramos JA; Fernández-Ruiz JJ
Drug Alcohol Depend; 1999 Jun; 55(1-2):127-36. PubMed ID: 10402157
[TBL] [Abstract][Full Text] [Related]
33. Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence.
Hungund BL; Basavarajappa BS
Alcohol Alcohol; 2000; 35(2):126-33. PubMed ID: 10787386
[TBL] [Abstract][Full Text] [Related]
34. Sex, THC, and hormones: Effects on density and sensitivity of CB
Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
[TBL] [Abstract][Full Text] [Related]
35. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme.
Hernández M; Berrendero F; Suárez I; García-Gil L; Cebeira M; Mackie K; Ramos JA; Fernández-Ruiz J
Brain Res; 2000 Feb; 857(1-2):56-65. PubMed ID: 10700552
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptor localization in brain.
Herkenham M; Lynn AB; Little MD; Johnson MR; Melvin LS; de Costa BR; Rice KC
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1932-6. PubMed ID: 2308954
[TBL] [Abstract][Full Text] [Related]
38. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew.
Darmani NA
Pharmacol Biochem Behav; 2001; 69(1-2):239-49. PubMed ID: 11420092
[TBL] [Abstract][Full Text] [Related]
39. Delta FosB and AP-1-mediated transcription modulate cannabinoid CB₁ receptor signaling and desensitization in striatal and limbic brain regions.
Lazenka MF; David BG; Lichtman AH; Nestler EJ; Selley DE; Sim-Selley LJ
Biochem Pharmacol; 2014 Oct; 91(3):380-9. PubMed ID: 25093286
[TBL] [Abstract][Full Text] [Related]
40. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ
Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
